Oleksandr Sydorenko

Statistics

Publications

Citations

243

H-Index

Active since

2011

Affiliations

Zaporizhzhia National University(Current)

Oleksandr Sydorenko is an author at Zaporizhzhia National University specializing in combination cancer therapy, malignant neoplasms, and chemotherapy.

Publications per year

2011–2014

Publications

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

Giorgio V. Scagliotti, Ihor Vynnychenko, Keunchil Park et al. · Journal of Clinical Oncology · 2012 · 183 citations · Full text

Medicine, Oncology, Pharmacology +17

Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study

Silvia Novello, Giorgio V. Scagliotti, Oleksandr Sydorenko et al. · Journal of Thoracic Oncology · 2014 · 36 citations · Full text

Medicine, Oncology, Pharmacology +12

An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC).

Giorgio V. Scagliotti, Ihor Vynnychenko, Y. Ichinose et al. · Journal of Clinical Oncology · 2011 · 24 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3